ECONOMYNEXT – Sri Lanka has administered the first dose of the China-donated Sinopharm COVID-19 vaccine and the Russian Sputnik V vaccine to 3,169 and 4,381 citizens respectively so far, the Health Ministry’s epidemiology unit said.
Sri Lanka started its vaccine rollout on January 29 this year, with 925,242 citizens including frontline workers in the health sector and the military receiving their first jab. Members of the public in select areas also received their first dose of this vaccine over the next few weeks.
The rollout was suspended on April 15 amid allegations that a priority list had been unceremoniously discarded leading to irregularities.
From April 23 to May 09, 196,546 people out of the 925,242 including frontline workers received their second dose of AstraZeneca.
Of a total of 1,264,000 of AstarZeneca doses either donated by the Indian government, received through the COVAX facility or purchased directly from the manufacturer, authorities retained 338,758 in storage to be administered as the second dose. As of today, 586,484 have yet to receive their second jab.
State Minister of Primary Health Care, Epidemics and COVID Disease Control Dr Sudarshini Fernandopulle told EconomyNext last week that authorities are looking at every possible avenue to acquire more doses for those still awaiting their second shot of AstraZeneca.
“There are countries that have purchased and stored excess consignments of the AstraZeneca jab. We’re talking to those governments to see if we can acquire vaccines from them,” she said.
Sri Lanka received 15,000 doses of the Russia-made Sputnik V vaccine on May 04, with rollout commencing two days later in Gothatuwa, Colombo. The jab has yet to be approved by the World Health Organisation (WHO) for emergency use.
In contrast, the 600,000 doses of Sinopharm donated by the Chinese government were sitting in stores since April till WHO approval was given to it apart from 2,435 doses administered to Chinese citizens in the country. The National Medicines Regulatory Authority (NMRA) had also not approved the Chinese jab until recently.
With WHO approval now granted, Sri Lanka has started rolling out Sinopharm to the general public since May 08. So far 3,169 Sri Lankans have received the jab.
Meanwhile, China is looking at contracting a Sri Lanka biotech company to fill and finish Sinopharm vaccines in Sri Lanka, the country’s embassy in Colombo said.
“The Embassy is working closely with Sri Lankan authorities to encourage biotech companies from China – Sri Lanka to collaborate on vax filling lines in the island,” the embassy said in a Twitter exchange with Munza Mushtaq a Sri Lanka based journalist. (Colombo/ May10/2021)